Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1/2 5Phase 1 5Phase NA 2Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 2

Interventions

Blood Specimen Collection 11Radiosurgery 7Sentinel Lymph Node Biopsy 5Early Intervention, Educational 5Surveys and Questionnaires 4Standard of Care 4Practice Guidelines as Topic 4Methods 4Indocyanine Green 4Educational Status 4X-Rays 3Surgical Procedures, Operative 3Nivolumab 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Immunotherapy 3Cognitive Behavioral Therapy 3Biopsy 3pembrolizumab 2montanide ISA 51 2aldesleukin 2Tomography, X-Ray Computed 2Tomography, Emission-Computed 2Specimen Handling 2Radiotherapy 2Radiation 2Positron-Emission Tomography 2Palliative Care 2Observation 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Melanoma × montanide ISA 51 × Clear all
NCT00006243 2013-01-25

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma

National Cancer Institute (NCI)

Phase NA Completed
30 enrolled
Dermatologic

Melanoma

NCT00912574 2009-06-03

MEL38

University of Virginia

Phase NA Completed
29 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡